Timothy M E Davis (Timothy M Davis, Timothy Me Davis, T M E Davis, Tim Davis, Wendy A Davis)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 81

Top Venues

Internal medicine journal

Journal of clinical medicine

Diabetes care

Diabetic medicine : a journal of the British Diabetic Association

University of Western Australia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Western Australia

Australia

Professor :: School of Medicine and Pharmacology

Publications

Timothy M E Davis, Kirsten E Peters, Wendy A Davis
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II. Internal medicine journal (2024)
Timothy M E Davis, Kirsten E Peters, Wendy A Davis
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II. Internal medicine journal 54 (3) (2024)
Timothy M E Davis, Kirsten E Peters, Wendy A Davis
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II. Internal medicine journal 54 (3) (2024)
Timothy M E Davis, Jocelyn J Drinkwater, Wendy A Davis
Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Diabetes care 47 (3) (2024)
Timothy M E Davis, Kirsten E Peters, Wendy A Davis
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II. Internal medicine journal 54 (3) (2024)
Timothy M E Davis, Jocelyn J Drinkwater, Wendy A Davis
Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Diabetes care (2024)
Timothy M E Davis, Stephen A P Chubb, Kirsten E Peters, Wendy A Davis
Serum vitamin B12, distal symmetrical polyneuropathy and anaemia in type 2 diabetes: the Fremantle Diabetes Study Phase 2. Internal medicine journal (2023)
Timothy M E Davis, Sharon Maxwell, Cathy Chan, Helen I Keen, Wendy A Davis
The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes. Diabetes, obesity & metabolism (2023)
Kirsten E Peters, Scott D Bringans, Ronan S O'Neill, Tasha S C Lumbantobing, James K C Lui, Timothy M E Davis, Michael K Hansen, Richard J Lipscombe
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores. Journal of clinical medicine 12 (9) (2023)
David G Bruce, Wendy A Davis, Timothy M E Davis
Group-Based Trajectory Modelling of Changes in Mobility over Six Years in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Journal of clinical medicine 12 (13) (2023)
Emma J Hamilton, Wendy A Davis, Mendel Baba, Timothy M E Davis
Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study. Diabetes & vascular disease research 20 (1) (2023)
Kirsten E Peters, Scott D Bringans, Ronan S O'Neill, Tasha S C Lumbantobing, James K C Lui, Timothy M E Davis, Michael K Hansen, Richard J Lipscombe
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores. Journal of clinical medicine 12 (9) (2023)
S A Paul Chubb, Wendy A Davis, Timothy M E Davis
Serum bicarbonate concentration and the risk of death in type 2 diabetes: the Fremantle Diabetes Study Phase II. Acta diabetologica (2023)
Wendy A Davis, David G Bruce, Timothy M E Davis, Sergio E Starkstein
The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase II. Journal of clinical medicine 12 (24) (2023)
Nishant Nundlall, David Playford, Geoffrey A Strange, Timothy M E Davis, Wendy A Davis
The Relationship between Pulmonary Artery Pressure and Mortality in Type 2 Diabetes: A Fremantle Diabetes Study Phase II and National Echocardiographic Database of Australia Data Linkage Study. Journal of clinical medicine 12 (24) (2023)
Nishant Nundlall, David Playford, Geoffrey A Strange, Timothy M E Davis, Wendy A Davis
The Relationship between Pulmonary Artery Pressure and Mortality in Type 2 Diabetes: A Fremantle Diabetes Study Phase II and National Echocardiographic Database of Australia Data Linkage Study. Journal of clinical medicine 12 (24) (2023)
Timothy M E Davis, Wendy Davis
The relationship between glycated haemoglobin and blood glucose-lowering treatment trajectories in type 2 diabetes: The Fremantle Diabetes Study Phase II. Diabetes, obesity & metabolism (2023)
Wendy A Davis, David G Bruce, Timothy M E Davis, Sergio E Starkstein
The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase II. Journal of clinical medicine 12 (24) (2023)
Timothy M E Davis, Emma Hamilton, Timothy M E Davis
Temporal trends in distal symmetric polyneuropathy in type 2 diabetes: The Fremantle Diabetes Study. The Journal of clinical endocrinology and metabolism (2023)
Emma J Hamilton, Wendy A Davis, Mendel Baba, Timothy M E Davis
Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study. Diabetes & vascular disease research 20 (1) (2023)
Ruwani Rajapaksa, Wendy A Davis, Timothy M E Davis
Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I. BMJ open diabetes research & care 11 (4) (2023)
Timothy M E Davis, Wendy A Davis
An assessment of factors contributing to the decline in risk of stroke complicating type 2 diabetes: The Fremantle Diabetes Study. Diabetes, obesity & metabolism (2023)
Emma J Hamilton, Wendy A Davis, Mendel Baba, Timothy M E Davis
Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study. Diabetes & vascular disease research 20 (1) (2023)
Emma J Hamilton, Wendy A Davis, Mendel Baba, Timothy M E Davis
Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study. Diabetes & vascular disease research 20 (1) (2023)
Wendy A Davis, David G Bruce, Sergio E Starkstein, Timothy M E Davis
Temporal Trends in Mortality Associated with Comorbid Type 2 Diabetes and Schizophrenia: The Fremantle Diabetes Study. Journal of clinical medicine 12 (1) (2022)
Timothy M E Davis, Peter G Colman, Charlotte Hespe, Sarah E Heywood, Michael d'Emden
Cardiovascular disease management in Australian adults with type 2 diabetes: insights from the CAPTURE study. Internal medicine journal (2022)
Wendy A Davis, David G Bruce, Sergio E Starkstein, Timothy M E Davis
Temporal Trends in Mortality Associated with Comorbid Type 2 Diabetes and Schizophrenia: The Fremantle Diabetes Study. Journal of clinical medicine 12 (1) (2022)
Wendy A Davis, Aron Chakera, Edward Gregg, Daniel McAullay, Timothy M E Davis
Temporal Trends in Renal Replacement Therapy in Community-Based People with or without Type 2 Diabetes: The Fremantle Diabetes Study. Journal of clinical medicine 11 (3) (2022)
Michael McCann, Aoife O'Brien, Robert Larbalestier, Timothy M E Davis
Sodium-glucose cotransport-2 inhibitor induced ketoacidosis following coronary artery bypass surgery: implications for management. Internal medicine journal 52 (5) (2022)
Jocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, Wendy A Davis
Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II. Diabetic medicine : a journal of the British Diabetic Association (2022)
Jocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, Wendy A Davis
Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II. Diabetic medicine : a journal of the British Diabetic Association 40 (4) (2022)
Timothy M E Davis, Wendy A Davis
The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I. Internal medicine journal 52 (7) (2022)
S A Paul Chubb, Kirsten E Peters, David G Bruce, Wendy A Davis, Timothy M E Davis
The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II. Acta diabetologica 59 (12) (2022)
Jocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, Wendy A Davis
Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II. Diabetic medicine : a journal of the British Diabetic Association 40 (4) (2022)
Jocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, Wendy A Davis
Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II. Diabetic medicine : a journal of the British Diabetic Association (2022)
Jocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, Wendy A Davis
Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II. Diabetic medicine : a journal of the British Diabetic Association 40 (4) (2022)
Wendy A Davis, David G Bruce, Sergio E Starkstein, Timothy M E Davis
Temporal Trends in Mortality Associated with Comorbid Type 2 Diabetes and Schizophrenia: The Fremantle Diabetes Study. Journal of clinical medicine 12 (1) (2022)
Jocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, Wendy A Davis
Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle Diabetes Study Phase II. Diabetic medicine : a journal of the British Diabetic Association (2022)
Tatsiana Yarash, Imrana Sharif, Farhat Masood, Rhonda M Clifford, Wendy A Davis, Timothy M E Davis
Complementary medicine use and its cost in Australians with type 2 diabetes: the Fremantle Diabetes Study Phase II. Internal medicine journal 50 (8) (2021)
Ranita Siru, Melanie S Burkhardt, Wendy A Davis, Jonathan Hiew, Laurens Manning, Jens Carsten Ritter, Paul E Norman, Ashley Makepeace, Peter Gerry Fegan, David G Bruce, Timothy M E Davis, Emma J Hamilton
Cognitive Impairment in People with Diabetes-Related Foot Ulceration. Journal of clinical medicine 10 (13) (2021)
Vidya Navaratnam, Timothy M E Davis, Richard Hubbard, Wendy A Davis
Incidence and predictors of idiopathic pulmonary fibrosis complicating Type 2 diabetes: the Fremantle Diabetes Study Phase I. Internal medicine journal 51 (2) (2021)
Michael L Hunter, Matthew W Knuiman, Arthur W Bill Musk, Jennie Hui, Kevin Murray, John P Beilby, David R Hillman, Joseph Hung, Robert U Newton, Romola S Bucks, Leon M Straker, John P Walsh, Kun Zhu, David G Bruce, Robert H Eikelboom, Timothy M E Davis, David A Mackey, Alan L James
Prevalence and patterns of multimorbidity in Australian baby boomers: the Busselton healthy ageing study. BMC public health 21 (1) (2021)
Sri Riyati Sugiarto, Balbir Singh, Madhu Page-Sharp, Wendy A Davis, Sam Salman, King Ching Hii, Timothy M E Davis
The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria. British journal of clinical pharmacology (2021)
Nishant Nundlall, David Playford, Geoff Strange, Timothy M E Davis, Wendy A Davis
Prevalence, Incidence and Associates of Pulmonary Hypertension Complicating Type 2 Diabetes: Insights from the Fremantle Diabetes Study Phase 2 and National Echocardiographic Database of Australia. Journal of clinical medicine 10 (19) (2021)
Emma J Hamilton, Wendy A Davis, Ranita Siru, Mendel Baba, Paul E Norman, Timothy M E Davis
Temporal Trends in Incident Hospitalization for Diabetes-Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study. Diabetes care 44 (3) (2021)
Timothy M E Davis, Jocelyn J Drinkwater, P Gerry Fegan, Krishnamurthy Chikkaveerappa, Brett Sillars, Wendy A Davis
Community-based management of complex type 2 diabetes: adaptation of an integrated model of care in a general practice setting. Internal medicine journal 51 (1) (2021)
Ezra B Ketema, Nigus Z Gishen, Abraha Hailu, Abadi Leul, Abera Hadgu Berhe, Kiflom Hagos, Samual Berhane, Temesgen Tsega Desta, Madhu Page-Sharp, Timothy M E Davis, Brioni R Moore, Kevin T Batty, Jonathan Carapetis, Sam Salman, Laurens Manning
High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease. PLoS neglected tropical diseases 15 (6) (2021)
Jocelyn J Drinkwater, Fred K Chen, A M Brooks, B T Davis, A W Turner, Timothy M E Davis, Wendy A Davis
The association between carotid disease, arterial stiffness and diabetic retinopathy in type 2 diabetes: the Fremantle Diabetes Study Phase II. Diabetic medicine : a journal of the British Diabetic Association 38 (4) (2020)
Jocelyn J Drinkwater, Fred K Chen, Alison M Brooks, Brad T Davis, Angus W Turner, Timothy M E Davis, Wendy A Davis
Carotid Disease and Retinal Optical Coherence Tomography Angiography Parameters in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Diabetes care 43 (12) (2020)
Wendy A Davis, Valentina Hellbusch, Michael L Hunter, David G Bruce, Timothy M E Davis
Contemporary Cardiovascular Risk Assessment for Type 2 Diabetes Including Heart Failure as an Outcome: The Fremantle Diabetes Study Phase II. Journal of clinical medicine 9 (5) (2020)
Shu Jin Tan, Matthew Cockcroft, Madhu Page-Sharp, Glenn Arendts, Timothy M E Davis, Brioni R Moore, Kevin T Batty, Sam Salman, Laurens Manning
Population Pharmacokinetic Study of Ceftriaxone in Elderly Patients, Using Cystatin C-Based Estimates of Renal Function To Account for Frailty. Antimicrobial agents and chemotherapy 64 (10) (2020)
Jocelyn J Drinkwater, Timothy M E Davis, Wendy A Davis
The relationship between carotid disease and retinopathy in diabetes: a systematic review. Cardiovascular diabetology 19 (1) (2020)
Timothy M E Davis, Wendy Davis
Incidence and associates of diabetic ketoacidosis in a community-based cohort: the Fremantle Diabetes Study Phase II. BMJ open diabetes research & care 8 (1) (2020)
Mohammad Sharif Hossain, Robert J Commons, Nicholas M Douglas, Kamala Thriemer, Bereket H Alemayehu, Chanaki Amaratunga, Anupkumar R Anvikar, Elizabeth A Ashley, Puji B S Asih, Verena Ilona Carrara, Chanthap Lon, Umberto D Alessandro, Timothy M E Davis, Arjen M Dondorp, Michael D Edstein, Rick M Fairhurst, Marcelo Urbano Ferreira, Jimee Hwang, Bart Janssens, Harin Karunajeewa, Jean R Kiechel, Simone Ladeia-Andrade, Moses Laman, Mayfong Mayxay, Rose McGready, Brioni R Moore, Ivo Mueller, Paul N Newton, Thuy-Nhien Nguyen, Harald Noedl, Francois H Nosten, Aung Pyae Phyo, Jeanne Rini Poespoprodjo, David L Saunders, Frank M Smithuis, Michele D Spring, Kasia Stepniewska, Seila Suon, Yupin Suputtamongkol, Din Syafruddin, Hien T Tran, Neena Valecha, Michel Van Herp, Michele Van Vugt, Nicholas J White, Philippe J Guerin, Julie Anne Simpson, Richard N Price
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network. PLoS medicine 17 (11) (2020)
Kirsten E Peters, Stephen A Paul Chubb, David G Bruce, Wendy A Davis, Timothy M E Davis
Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II. Clinical endocrinology 92 (4) (2020)
Timothy M E Davis, Kirsten E Peters, S A Paul Chubb, Leon A Adams, Gary P Jeffrey, Wendy A Davis
Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. Journal of clinical medicine 9 (11) (2020)
Timothy M E Davis, Wendy A Davis
Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Diabetes care 43 (9) (2020)
Jocelyn J Drinkwater, Wendy A Davis, Angus W Turner, Daniel McAullay, Timothy M E Davis
Differences in retinopathy prevalence and progression between Anglo-Celt and Aboriginal Australians: The Fremantle Diabetes Study Phase II. Internal medicine journal (2020)
Jocelyn J Drinkwater, Timothy M E Davis, Valentina Hellbusch, Angus W Turner, David G Bruce, Wendy A Davis
Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II. Cardiovascular diabetology 19 (1) (2020)
Brioni R Moore, Timothy M E Davis
Updated pharmacokinetic considerations for the use of antimalarial drugs in pregnant women. Expert opinion on drug metabolism & toxicology 16 (9) (2020)
Brioni R Moore, John M Benjamin, Roselyn Tobe, Maria Ome-Kaius, Gumul Yadi, Bernadine Kasian, Charles Kong, Leanne J Robinson, Moses Laman, Ivo Mueller, Stephen Rogerson, Timothy M E Davis
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women. Antimicrobial agents and chemotherapy 63 (10) (2019)
Robert J Commons, Julie Anne Simpson, Kamala Thriemer, Tesfay Abreha, Abdelmageed Elmugabil, Nicholas M Anstey, Ashenafi Assefa, Ghulam R Awab, J Kevin Baird, Bridget E Barber, Cindy S Chu, Prabin Dahal, André Daher, Timothy M E Davis, Arjen M Dondorp, Matthew J Grigg, Georgina S Humphreys, Jimee Hwang, Harin Karunajeewa, Moses Laman, Kartini Lidia, Brioni R Moore, Ivo Mueller, Francois H Nosten, Ayodhia Pitaloka Pasaribu, Dhelio Batista Pereira, Aung Pyae Phyo, Jeanne Rini Poespoprodjo, Carol H Sibley, Kasia Stepniewska, Inge Sutanto, Guy Thwaites, Tran T Hien, Nicholas J White, Timothy William, Charles J Woodrow, Philippe J Guerin, Richard N Price
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis. PLoS medicine 16 (10) (2019)
Timothy M E Davis, Stephen A P Chubb, Bradley H Curtis, Helen Barraclough, Wendy A Davis
Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes Study. Internal medicine journal 48 (10) (2019)
Wendy A Davis, Emma J Hamilton, David G Bruce, Timothy M E Davis
Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102-109. Diabetes care 42 (6) (2019)
Wendy A Davis, Kirsten E Peters, Ashley Makepeace, Shaye Griffiths, Christine Bundell, Struan F A Grant, Sian Ellard, Andrew T Hattersley, Stephen A Paul Chubb, David G Bruce, Timothy M E Davis
Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II. Internal medicine journal 48 (7) (2018)
Timothy M E Davis
Author reply. Internal medicine journal 48 (3) (2018)
Timothy M E Davis, David G Bruce, Judith Finn, Bradley H Curtis, Helen Barraclough, Wendy A Davis
Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study. Diabetes, obesity & metabolism 21 (3) (2018)
Mispah Mukap, Corin Sprod, Nakapi Tefuarani, Moses Laman, Madhu Page-Sharp, Sam Salman, Brioni R Moore, Kevin T Batty, Timothy M E Davis, Laurens Manning
Validation of a Dried Blood Spot Ceftriaxone Assay in Papua New Guinean Children with Severe Bacterial Infections. Antimicrobial agents and chemotherapy 62 (10) (2018)
Timothy M E Davis, Jane Kauhanen, Wendy A Davis
Pneumococcal vaccination and incident hospitalisation for pneumonia in type 2 diabetes: the Fremantle Diabetes Study Phase II. Internal medicine journal 47 (10) (2018)
Jocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, David G Bruce, Wendy A Davis
Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Diabetes care 42 (2) (2018)
Brioni R Moore, Timothy M E Davis
Pharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challenges. Expert opinion on pharmacotherapy 19 (16) (2018)
Wendy A Davis, Emma J Hamilton, David G Bruce, Timothy M E Davis
Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes care 42 (1) (2018)
David G Bruce, Wendy A Davis, Timothy M E Davis
Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II. Diabetes, obesity & metabolism 20 (12) (2018)
Timothy M E Davis, Hillary Mulder, Yuliya Lokhnygina, Pablo Aschner, Lee-Ming Chuang, Carlos A Raffo Grado, Eberhard Standl, Eric D Peterson, Rury R Holman, null null
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Diabetes, obesity & metabolism 20 (6) (2018)
Timothy M E Davis, Imran Badshah, Jocelyn Drinkwater, Emily Kusich, Erin Latkovic, Neville Knuckey
Two-year audit of outcomes of pituitary surgery at an Australian teaching hospital. Internal medicine journal 47 (11) (2018)
Madhu Page-Sharp, Jonathan Coward, Brioni R Moore, Sam Salman, Lewis Marshall, Timothy M E Davis, Kevin T Batty, Laurens Manning
Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever. Antimicrobial agents and chemotherapy 61 (8) (2017)
Sam Salman, Francisca Baiwog, Madhu Page-Sharp, Susan Griffin, Harin A Karunajeewa, Ivo Mueller, Stephen J Rogerson, Peter M Siba, Kenneth F Ilett, Timothy M E Davis
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 61 (5) (2017)
Kirsten E Peters, Wendy A Davis, Jun Ito, Kaye Winfield, Thomas Stoll, Scott D Bringans, Richard J Lipscombe, Timothy M E Davis
Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Diabetes care 40 (11) (2017)
Brioni R Moore, Wendy A Davis, Philip M Clarke, Leanne J Robinson, Moses Laman, Timothy M E Davis
Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children. Malaria journal 16 (1) (2017)
Sri Riyati Sugiarto, Timothy M E Davis, Sam Salman
Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations. Expert opinion on drug metabolism & toxicology 13 (11) (2017)
S A Paul Chubb, Wendy A Davis, Kirsten E Peters, Timothy M E Davis
Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study. Cardiovascular diabetology 15 (1) (2016)

Timothy M E Davis.css-eqlu8i{font-size:small;padding-left:4px;} (Timothy M Davis, Timothy Me Davis, T M E Davis, Tim Davis, Wendy A Davis)

Publication Activity (10 Years)

Top Topics

Top Venues

Timothy M E Davis (Timothy M Davis, Timothy Me Davis, T M E Davis, Tim Davis, Wendy A Davis)